Low-dose aspirin linked to reduced liver cancer risk
Among adults with chronic viral hepatitis at high risk of liver cancer, those who took low-dose aspirin long-term were less likely to develop liver cancer or to die from liver-related causes. The findings come from a study published in the New England Journal of Medicine and conducted by a team led by investigators at Karolinska Institutet and Örebro University Hospital in Sweden and Massachusetts General Hospital in the U.S.“Rates of liver cancer and of mortality from liver disease are rising at an alarming pace in the U.S. and European countries,” says lead author Tracey Simon, researcher